| 摘要 |
The present invention relates to a cyclosporin-containing soft capsule preparation which comprises cyclosporin as an active ingredient; propylene carbonate or polyethylene glycol or a mixture thereof as a cosurfactant; one or a mixture of two or more selected from the group consisting of an esterified compound of fatty acid and primary alcohol, medium chain fatty acid triglyceride and fatty acid monoglyceride as an oil component; and a surfactant having HLB (Hydrophilic-lipophilic balance) value of 8 to 17. |
